Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Williams Syndrome | 6 | 2024 | 187 | 3.750 |
Why?
|
Catatonia | 2 | 2023 | 158 | 1.420 |
Why?
|
Anti-Anxiety Agents | 2 | 2024 | 390 | 1.380 |
Why?
|
Clozapine | 2 | 2023 | 498 | 1.340 |
Why?
|
Delirium | 6 | 2022 | 1609 | 1.270 |
Why?
|
Buspirone | 3 | 2024 | 82 | 1.120 |
Why?
|
Tics | 2 | 2023 | 70 | 1.040 |
Why?
|
Psychotropic Drugs | 2 | 2021 | 894 | 0.900 |
Why?
|
Psychopharmacology | 2 | 2021 | 143 | 0.870 |
Why?
|
Stereotypic Movement Disorder | 1 | 2021 | 29 | 0.800 |
Why?
|
Suicidal Ideation | 2 | 2021 | 1248 | 0.770 |
Why?
|
Down Syndrome | 2 | 2024 | 880 | 0.650 |
Why?
|
Antipsychotic Agents | 4 | 2022 | 3058 | 0.640 |
Why?
|
Conversion Disorder | 1 | 2021 | 205 | 0.640 |
Why?
|
Indenes | 1 | 2018 | 57 | 0.620 |
Why?
|
Behavior Control | 1 | 2017 | 45 | 0.590 |
Why?
|
Anxiety Disorders | 6 | 2024 | 2691 | 0.590 |
Why?
|
Mental Disorders | 4 | 2021 | 6601 | 0.580 |
Why?
|
Psychotic Disorders | 3 | 2021 | 3046 | 0.570 |
Why?
|
Patient Rights | 1 | 2017 | 126 | 0.550 |
Why?
|
Comorbidity | 7 | 2022 | 10387 | 0.550 |
Why?
|
Health Records, Personal | 1 | 2017 | 124 | 0.530 |
Why?
|
Hallucinations | 1 | 2017 | 360 | 0.510 |
Why?
|
Treatment Refusal | 1 | 2016 | 421 | 0.440 |
Why?
|
Sex Offenses | 1 | 2017 | 354 | 0.430 |
Why?
|
Melatonin | 1 | 2018 | 721 | 0.430 |
Why?
|
Interpersonal Relations | 1 | 2020 | 1424 | 0.430 |
Why?
|
Depressive Disorder, Major | 2 | 2021 | 4645 | 0.430 |
Why?
|
Longevity | 1 | 2020 | 1069 | 0.420 |
Why?
|
Stereotyped Behavior | 2 | 2023 | 136 | 0.410 |
Why?
|
Ethics, Medical | 1 | 2017 | 792 | 0.400 |
Why?
|
Stem Cell Transplantation | 1 | 2020 | 1620 | 0.390 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2024 | 3658 | 0.390 |
Why?
|
Hydronephrosis | 1 | 2012 | 269 | 0.390 |
Why?
|
Disclosure | 1 | 2017 | 736 | 0.380 |
Why?
|
Immunologic Factors | 1 | 2020 | 1582 | 0.380 |
Why?
|
Psychotherapy | 1 | 2019 | 1645 | 0.350 |
Why?
|
Psychiatry | 2 | 2019 | 1695 | 0.350 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2136 | 0.340 |
Why?
|
Referral and Consultation | 2 | 2019 | 3528 | 0.340 |
Why?
|
Physician's Role | 1 | 2016 | 942 | 0.340 |
Why?
|
Neovascularization, Physiologic | 2 | 2014 | 1351 | 0.330 |
Why?
|
Critical Illness | 2 | 2018 | 2670 | 0.330 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1438 | 0.330 |
Why?
|
Language | 2 | 2020 | 1471 | 0.330 |
Why?
|
Patient Discharge | 1 | 2021 | 3313 | 0.310 |
Why?
|
Humans | 46 | 2024 | 744220 | 0.300 |
Why?
|
Sexual Behavior | 1 | 2017 | 2056 | 0.300 |
Why?
|
Dementia | 2 | 2017 | 2518 | 0.270 |
Why?
|
Education, Medical | 2 | 2018 | 1721 | 0.260 |
Why?
|
Diagnosis, Differential | 4 | 2023 | 12961 | 0.250 |
Why?
|
Multiple Sclerosis | 1 | 2019 | 3079 | 0.240 |
Why?
|
Child | 13 | 2024 | 77679 | 0.240 |
Why?
|
Guanfacine | 1 | 2024 | 51 | 0.240 |
Why?
|
Mass Screening | 1 | 2019 | 5252 | 0.230 |
Why?
|
Adolescent | 11 | 2024 | 85759 | 0.230 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3227 | 0.230 |
Why?
|
Lorazepam | 1 | 2023 | 145 | 0.220 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3506 | 0.220 |
Why?
|
Cognition Disorders | 1 | 2017 | 4041 | 0.210 |
Why?
|
Compulsive Behavior | 1 | 2023 | 117 | 0.210 |
Why?
|
Anxiety | 4 | 2024 | 4297 | 0.210 |
Why?
|
Hypertension | 1 | 2022 | 8480 | 0.210 |
Why?
|
Double-Blind Method | 3 | 2024 | 12035 | 0.200 |
Why?
|
Muscle, Skeletal | 2 | 2014 | 4935 | 0.190 |
Why?
|
Nausea | 1 | 2024 | 668 | 0.190 |
Why?
|
Irritable Mood | 1 | 2021 | 183 | 0.190 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5755 | 0.180 |
Why?
|
Delayed-Action Preparations | 1 | 2024 | 964 | 0.180 |
Why?
|
Retrospective Studies | 8 | 2024 | 77426 | 0.180 |
Why?
|
Angelman Syndrome | 1 | 2022 | 136 | 0.180 |
Why?
|
Inpatients | 2 | 2022 | 2518 | 0.180 |
Why?
|
Bipolar Disorder | 1 | 2017 | 5027 | 0.170 |
Why?
|
Hospitalization | 5 | 2022 | 10262 | 0.150 |
Why?
|
Psychiatric Department, Hospital | 1 | 2018 | 135 | 0.150 |
Why?
|
Olfactory Perception | 1 | 2017 | 54 | 0.150 |
Why?
|
Beneficence | 1 | 2017 | 53 | 0.150 |
Why?
|
Dystonia | 1 | 2020 | 363 | 0.140 |
Why?
|
Observation | 1 | 2018 | 312 | 0.140 |
Why?
|
Prevalence | 3 | 2022 | 15226 | 0.140 |
Why?
|
Haloperidol | 1 | 2017 | 397 | 0.130 |
Why?
|
Benzodiazepines | 2 | 2022 | 1101 | 0.130 |
Why?
|
Biomedical Technology | 1 | 2018 | 221 | 0.130 |
Why?
|
Models, Educational | 1 | 2018 | 377 | 0.130 |
Why?
|
Intensive Care Units | 2 | 2018 | 3680 | 0.130 |
Why?
|
Stereotyping | 1 | 2017 | 241 | 0.130 |
Why?
|
Risperidone | 1 | 2017 | 383 | 0.130 |
Why?
|
Cannabis | 1 | 2021 | 438 | 0.130 |
Why?
|
Coma | 1 | 2018 | 475 | 0.130 |
Why?
|
Transcription Factors | 2 | 2014 | 12207 | 0.120 |
Why?
|
Personal Autonomy | 1 | 2017 | 298 | 0.120 |
Why?
|
Patient Advocacy | 1 | 2016 | 353 | 0.120 |
Why?
|
Immune System | 1 | 2019 | 805 | 0.110 |
Why?
|
Central Nervous System Stimulants | 1 | 2022 | 1148 | 0.110 |
Why?
|
Social Behavior | 1 | 2020 | 1127 | 0.110 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2020 | 1953 | 0.110 |
Why?
|
Brain | 2 | 2020 | 26413 | 0.110 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2021 | 6037 | 0.110 |
Why?
|
Social Justice | 1 | 2017 | 456 | 0.110 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2021 | 1444 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2024 | 10949 | 0.100 |
Why?
|
Vulnerable Populations | 1 | 2017 | 686 | 0.100 |
Why?
|
Cell Hypoxia | 1 | 2014 | 675 | 0.100 |
Why?
|
Treatment Outcome | 4 | 2024 | 63119 | 0.100 |
Why?
|
Patient Preference | 1 | 2018 | 887 | 0.100 |
Why?
|
Quality of Life | 2 | 2023 | 12805 | 0.100 |
Why?
|
Overweight | 1 | 2022 | 2370 | 0.100 |
Why?
|
Cooperative Behavior | 1 | 2018 | 1504 | 0.090 |
Why?
|
Social Stigma | 1 | 2017 | 701 | 0.090 |
Why?
|
China | 1 | 2016 | 2247 | 0.090 |
Why?
|
Adult | 6 | 2023 | 214035 | 0.090 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2012 | 504 | 0.090 |
Why?
|
Urinary Tract | 1 | 2012 | 308 | 0.080 |
Why?
|
Suicide | 1 | 2019 | 1477 | 0.080 |
Why?
|
Female | 10 | 2022 | 380197 | 0.080 |
Why?
|
Young Adult | 4 | 2023 | 56436 | 0.080 |
Why?
|
Alternative Splicing | 1 | 2014 | 1118 | 0.080 |
Why?
|
Middle Aged | 6 | 2019 | 213367 | 0.080 |
Why?
|
Exons | 1 | 2014 | 2439 | 0.080 |
Why?
|
Male | 10 | 2022 | 350027 | 0.080 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 783 | 0.080 |
Why?
|
Communication | 1 | 2021 | 3749 | 0.080 |
Why?
|
Disabled Persons | 1 | 2017 | 1212 | 0.070 |
Why?
|
Physical Conditioning, Animal | 1 | 2009 | 362 | 0.070 |
Why?
|
Stress, Psychological | 1 | 2021 | 4245 | 0.070 |
Why?
|
Internet | 1 | 2018 | 3063 | 0.070 |
Why?
|
Survival Analysis | 1 | 2018 | 10250 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6308 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4216 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9960 | 0.060 |
Why?
|
Risk Factors | 2 | 2021 | 72280 | 0.060 |
Why?
|
Obsessive Behavior | 1 | 2021 | 47 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19907 | 0.050 |
Why?
|
Child, Preschool | 2 | 2022 | 40992 | 0.050 |
Why?
|
Phenotype | 2 | 2020 | 16365 | 0.050 |
Why?
|
Ophthalmoplegia, Chronic Progressive External | 1 | 2020 | 17 | 0.050 |
Why?
|
Mitochondria | 1 | 2014 | 3520 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2018 | 4266 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7659 | 0.040 |
Why?
|
Obesity | 1 | 2022 | 12742 | 0.040 |
Why?
|
Trans-Activators | 1 | 2009 | 2924 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2020 | 323 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4465 | 0.040 |
Why?
|
Cell Line | 1 | 2014 | 15999 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10634 | 0.040 |
Why?
|
Prednisolone | 1 | 2020 | 334 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23337 | 0.040 |
Why?
|
Internship and Residency | 1 | 2018 | 5787 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39045 | 0.040 |
Why?
|
Time Factors | 1 | 2018 | 40063 | 0.040 |
Why?
|
Animals | 3 | 2020 | 168788 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2020 | 1401 | 0.030 |
Why?
|
Syndrome | 1 | 2020 | 3250 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1456 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2016 | 57768 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2018 | 1199 | 0.020 |
Why?
|
Faculty, Medical | 1 | 2018 | 1181 | 0.020 |
Why?
|
Angiogenic Proteins | 1 | 2009 | 104 | 0.020 |
Why?
|
Signal Transduction | 1 | 2012 | 23404 | 0.020 |
Why?
|
Mice | 2 | 2014 | 81178 | 0.020 |
Why?
|
Aged | 1 | 2021 | 163253 | 0.020 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2009 | 246 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8321 | 0.020 |
Why?
|
Peripheral Vascular Diseases | 1 | 2009 | 550 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 53280 | 0.020 |
Why?
|
Students, Medical | 1 | 2018 | 1862 | 0.020 |
Why?
|
Pain | 1 | 2020 | 4987 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1782 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15538 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5867 | 0.010 |
Why?
|
United States | 1 | 2022 | 69867 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 21824 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 12075 | 0.010 |
Why?
|
Concepts
(173)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_